Archive for the ‘Drugs’ Category
Posted by James
Sodium Oxybate Oral Solution (Xyrem)
Manufacturer: Jazz Pharmaceuticals, Palo Alto, CA Indication: Sodium oxybate is indicated for the treatment of excessive daytime sleepiness in patients with narcolepsy. The drug was originally approved as the first and only treatment for cataplexy in patients with narcolepsy. (Cataplectic patients experience a sudden loss of muscle tone and fall to the floor.)
Biological Class: Sodium oxybate is a sodium salt of gamma-hydroxybutyrate (GHB). GHB is a substance that is frequently abused when acquired illicitly and used illegally.
Read the rest of this entry »
Posted by James
Nelarabine (Arranon) Injection
Manufacturer: GlaxoSmithKline, Inc., Research Triangle Park, NC
Indication: Nelarabine is indicated for the treatment of adults and children with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It is used when the disease has not responded to or has returned after at least two chemotherapy regimens.
Read the rest of this entry »
Posted by James
Erlotinib (Tarceva)
Manufacturer: Genentech, Inc./OSI Pharmaceuticals, Inc.
Indication: Erlotinib (Tarceva), in combination with gemcitabine (Gemzar, Eli Lilly), is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
Drug Class: Erlotinib is a human epidermal growth factor receptor type-1/epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor. Its chemical name is N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazo-linamine.
Read the rest of this entry »